Omeros reported $314.36M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 312.13M 0.45M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Cytokinetics CYTK:US $ 198.42M 1.34M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Insmed INSM:US $ 807.11M 447K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Knight Therapeutics Inc GUD:CN C$ 11.86M 2.11M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 314.36M 454K
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Regulus Therapeutics RGLS:US $ 2.79M 0.79M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 0